Verified Nov 2026
Batteries & E-Mobility
·
San Francisco, California
·
Since 2016
Stämm is a biotechnology company headquartered in San Francisco, California, founded in 2016 and reporting an estimated 100 to 200 employees and revenue of $50 to $100 million (estimated band). It is privately held. The company develops compact, plug-and-play desktop systems for biomanufacturing, including its Bioprocessor, a 3D-printed microfluidic bioreactor for continuous, bubble-free cell production. It serves the automotive, medical, and industrial sectors as well as biotech and research users.
Stämm at a glance
Revenue
$50-100M
Est. band
Employees
100-200
Founded
2016
Headquarters
San Francisco, California
Industries
Automotive
Electric Vehicles
Medical
Plumbing & Hardware
Industrial Equipment
Overview
Stämm is a biotechnology company headquartered in San Francisco, California, founded in 2016 and reporting an estimated 100 to 200 employees and revenue of $50 to $100 million (estimated band). It is privately held. The company develops compact, plug-and-play desktop systems for biomanufacturing, including its Bioprocessor, a 3D-printed microfluidic bioreactor for continuous, bubble-free cell production. It serves the automotive, medical, and industrial sectors as well as biotech and research users.
At a glance
Attribute | Detail |
|---|---|
Founded | 2016 |
Headquarters | San Francisco, California |
Employees | 100-200 |
Revenue | $50-100M (estimated) |
Primary capability | Batteries & E-Mobility |
What Stämm makes
Stämm's listed product line includes a suspension-format offering, and its website describes an AI-powered Transomics Platform for cell line development and process optimization.
Products and capabilities described on the company's own site include Suspension (source: stamm.bio).
Latest developments
2026-10-29 — Stämm at Meeting on the Mesa 2026: Scaling Cell Therapies - Stämm (stamm.bio)
2026-03-12 — Stämm Redefines Biomanufacturing With a Bubble-Free, High-Throughput Bioprocessor Built for Decentralized Production - Stämm (stamm.bio)
2025-02-04 — Stämm and SuperMeat Collaborate to Accelerate Cultivated Meat Biomanufacturing, with Support from Mutual Investor Varana Capital - Stämm (stamm.bio)
2025-01-17 — A novel computational AI platform by Stämm models Cell Biomolecular Behavior to Accelerate wetlab bio-innovation cycles - Stämm (stamm.bio)
Company details
Stämm is privately held, and the record lists no named customers or certifications. Stämm was founded in 2016, has an estimated 100-200 employees, and is headquartered in San Francisco, California.
Frequently asked questions
What does Stämm make?
Stämm is a biotechnology company headquartered in San Francisco, California, founded in 2016 and reporting an estimated 100 to 200 employees and revenue of $50 to $100 million (estimated band). It is privately held. The company develops compact, plug-and-play desktop systems for biomanufacturing, including its Bioprocessor, a 3D-printed microfluidic bioreactor for continuous, bubble-free cell production. It serves the automotive, medical, and industrial sectors as well as biotech and research users.
Where is Stämm headquartered?
Stämm is headquartered in San Francisco, California (220 Halleck St, San Francisco, California, 94129).
When was Stämm founded?
Stämm was founded in 2016.
How big is Stämm?
Stämm has an estimated 100-200 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.